Get To Know Severe Asthma: The Chronic, Life-Threatening Condition Affecting 7-11% Adults In Asian Countries

September 25, 2024 01:00 PM AEST | By Cision
 Get To Know Severe Asthma: The Chronic, Life-Threatening Condition Affecting 7-11% Adults In Asian Countries
Image source: Kalkine Media

KUALA LUMPUR, Malaysia, Sept. 25, 2024 /PRNewswire/ -- Asthma is well-known as a common respiratory condition. But did you know that there exists a life-threatening type of the condition called severe asthma, that requires specialised, multidisciplinary treatment to manage?

Severe asthma is estimated to affect 7% to 11% of adults in Asian countries[i], while worldwide the condition affects 3%-10% of adults with asthma.[ii] Globally, severe asthma causes 1,000 deaths daily[iii]. While its prevalence in Malaysia has not been quantified, many patients in the country battle severe asthma regularly. 

Patients with severe asthma face challenging and often unpredictable symptoms, such as difficulty breathing, wheezing, and coughing.[iv] They also suffer intense asthma attacks which can occur frequently, impairing the patient's quality of life. Among children living with severe asthma, the symptoms also include speech limitation and sleep disturbance for at least one night per week.[v]

Severe asthma is different from other types of asthma, where more targeted, specialised treatment is required to manage the symptoms and curb asthma attacks. If not managed consistently, severe asthma can cause serious impairment in a person's life. Patients need the right, consistent treatment and specialist attention to manage this condition.

Early diagnosis is key to managing severe asthma

Early diagnosis of severe asthma is essential for patients to start their treatment plan sooner, leading to better management of their symptoms. Catching the severity in its early stages helps initiate tailored treatment options faster, improving the patient's quality of life.

Dedicated clinics for severe asthma that operate in the country often provide specialised care from medical experts from different disciplines, such as doctors and respiratory pharmacists. These clinics also offer other dedicated services to aid the diagnosis and management of severe asthma.

These services include diagnosis tests, such as spirometry or lung function tests, or a FeNO test (fractional exhaled nitric oxide) that can be conducted to determine lung inflammation. Other available tests include allergen testing and sleep study which may be required in a certain subgroup of patients.

Taking control of severe asthma

Severe asthma can be difficult for patients manage, as the condition generally does not respond well to usual asthma treatments. Symptoms of asthma are also harder to control with inhalers, even if the dosage is increased. This can be due to several causes, including the nature of the disease itself. Patients may require more specialised treatment to control the symptoms and reduce asthma attacks, such as biologic treatments.[vi]

Patients are also advised to consistently monitor their condition and track the symptoms that occur to better anticipate their needs and form more effective treatment plans together with their doctor.

Patients who suffer severe asthma attacks are encouraged to consult a healthcare professional for proper management of the condition. 

[i] Dhar, R., Ip, M., Kulkarni, T., Kim, H., Perng, W., Yao, X., Iwanaga, T., & Koh, M. S. (2020). Challenges faced in managing adult asthma: A perspective from Asian countries. Respirology, 25(12), 1235-1242. https://doi.org/10.1111/resp.13935

[ii] Israel, E., & Reddel, H. K. (2017). Severe and Difficult-to-Treat asthma in adults. New England Journal of Medicine/˜the œNew England Journal of Medicine, 377(10), 965–976. https://doi.org/10.1056/nejmra1608969 

[iii] Global Asthma Network. 2022. The Global Asthma Report. The International Journal of Tuberculosis and Lung Disease 26(Supp 1): 1-104

[iv] https://asthmamalaysia.org/understanding-asthma/ 

[v] Institute for Public Health 2024. National Health and Morbidity Survey (NHMS) 2023: Non-communicable Diseases and Healthcare Demand - Key Findings

[vi] https://www.healthline.com/health/severe-asthma#finding-treatment

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next

Top ASX Listed Companies


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.